<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>00616258025193</udiDi>
    <basicUdiDi>0616258TFCN-0060Q8</basicUdiDi>
    <tradeName>MEDRAD® Avanta Fluid Management Injection System</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Bayer Medical Care Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000007050</manufacturerSrn>
    <authorisedRepresentativeName>Bayer Medical Care B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000240</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Z11039013</emdnCode>
    <emdnDescription>ANGIOGRAPHIC INJECTORS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>AVA 500 TABL</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-22T14:17:51.754Z</lastUpdated>
  </row>
  <row>
    <udiDi>00616258025209</udiDi>
    <basicUdiDi>0616258TFCN-0060Q8</basicUdiDi>
    <tradeName>MEDRAD® Avanta Fluid Management Injection System</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Bayer Medical Care Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000007050</manufacturerSrn>
    <authorisedRepresentativeName>Bayer Medical Care B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000240</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Z11039013</emdnCode>
    <emdnDescription>ANGIOGRAPHIC INJECTORS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>AVA 500 PEDL</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-22T14:17:51.729Z</lastUpdated>
  </row>
  <row>
    <udiDi>00616258025308</udiDi>
    <basicUdiDi>0616258TFCN-0081IIbYU</basicUdiDi>
    <tradeName>MEDRAD® Mark 7 Arterion Injection System</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Bayer Medical Care Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000007050</manufacturerSrn>
    <authorisedRepresentativeName>Bayer Medical Care B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000240</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Z11039013</emdnCode>
    <emdnDescription>ANGIOGRAPHIC INJECTORS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ART 700 FS</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-22T14:17:51.640Z</lastUpdated>
  </row>
  <row>
    <udiDi>00616258025315</udiDi>
    <basicUdiDi>0616258TFCN-0081IIbYU</basicUdiDi>
    <tradeName>MEDRAD® Mark 7 Arterion Injection System</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Bayer Medical Care Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000007050</manufacturerSrn>
    <authorisedRepresentativeName>Bayer Medical Care B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000240</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Z11039013</emdnCode>
    <emdnDescription>ANGIOGRAPHIC INJECTORS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ART 700 HS6</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-22T14:17:51.613Z</lastUpdated>
  </row>
  <row>
    <udiDi>00616258025322</udiDi>
    <basicUdiDi>0616258TFCN-0081IIbYU</basicUdiDi>
    <tradeName>MEDRAD® Mark 7 Arterion Injection System</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Bayer Medical Care Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000007050</manufacturerSrn>
    <authorisedRepresentativeName>Bayer Medical Care B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000240</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Z11039013</emdnCode>
    <emdnDescription>ANGIOGRAPHIC INJECTORS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ART 700 HS12</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-22T14:17:51.594Z</lastUpdated>
  </row>
  <row>
    <udiDi>00616258025339</udiDi>
    <basicUdiDi>0616258TFCN-0081IIbYU</basicUdiDi>
    <tradeName>MEDRAD® Mark 7 Arterion Injection System</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Bayer Medical Care Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000007050</manufacturerSrn>
    <authorisedRepresentativeName>Bayer Medical Care B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000240</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Z11039013</emdnCode>
    <emdnDescription>ANGIOGRAPHIC INJECTORS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ART 700 HM</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-22T14:17:51.580Z</lastUpdated>
  </row>
  <row>
    <udiDi>00616258027173</udiDi>
    <basicUdiDi>0616258TFCN-0081IIbYU</basicUdiDi>
    <tradeName>MEDRAD® Mark 7 Arterion Injection System</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Bayer Medical Care Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000007050</manufacturerSrn>
    <authorisedRepresentativeName>Bayer Medical Care B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000240</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Z11039013</emdnCode>
    <emdnDescription>ANGIOGRAPHIC INJECTORS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ART 700 HM</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-22T14:17:51.153Z</lastUpdated>
  </row>
  <row>
    <udiDi>00616258027227</udiDi>
    <basicUdiDi>0616258TFCN-0081IIbYU</basicUdiDi>
    <tradeName>MEDRAD® Mark 7 Arterion Injection System</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Bayer Medical Care Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000007050</manufacturerSrn>
    <authorisedRepresentativeName>Bayer Medical Care B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000240</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Z11039013</emdnCode>
    <emdnDescription>ANGIOGRAPHIC INJECTORS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ART 700 HS12</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-22T14:17:51.065Z</lastUpdated>
  </row>
  <row>
    <udiDi>00616258027234</udiDi>
    <basicUdiDi>0616258TFCN-0081IIbYU</basicUdiDi>
    <tradeName>MEDRAD® Mark 7 Arterion Injection System</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Bayer Medical Care Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000007050</manufacturerSrn>
    <authorisedRepresentativeName>Bayer Medical Care B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000240</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Z11039013</emdnCode>
    <emdnDescription>ANGIOGRAPHIC INJECTORS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ART 700 HS6</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-22T14:17:51.049Z</lastUpdated>
  </row>
  <row>
    <udiDi>00616258027241</udiDi>
    <basicUdiDi>0616258TFCN-0081IIbYU</basicUdiDi>
    <tradeName>MEDRAD® Mark 7 Arterion Injection System</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Bayer Medical Care Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000007050</manufacturerSrn>
    <authorisedRepresentativeName>Bayer Medical Care B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000240</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Z11039013</emdnCode>
    <emdnDescription>ANGIOGRAPHIC INJECTORS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ART 700 FS</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-22T14:17:51.028Z</lastUpdated>
  </row>
  <row>
    <udiDi>09345390000737</udiDi>
    <basicUdiDi>934539000TFCN-0102UU</basicUdiDi>
    <tradeName>MEDRAD® Salient Contrast Injection System</tradeName>
    <deviceName></deviceName>
    <manufacturerName>IMAXEON PTY LTD</manufacturerName>
    <manufacturerSrn>AU-MF-000009702</manufacturerSrn>
    <authorisedRepresentativeName>Bayer Medical Care B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000240</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Z11039013</emdnCode>
    <emdnDescription>ANGIOGRAPHIC INJECTORS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>DC009D</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T14:34:33.982Z</lastUpdated>
  </row>
  <row>
    <udiDi>09345390000744</udiDi>
    <basicUdiDi>934539000TFCN-0102UU</basicUdiDi>
    <tradeName>MEDRAD® Salient Contrast Injection System</tradeName>
    <deviceName></deviceName>
    <manufacturerName>IMAXEON PTY LTD</manufacturerName>
    <manufacturerSrn>AU-MF-000009702</manufacturerSrn>
    <authorisedRepresentativeName>Bayer Medical Care B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000240</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Z11039013</emdnCode>
    <emdnDescription>ANGIOGRAPHIC INJECTORS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>DC009SW</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T14:34:33.965Z</lastUpdated>
  </row>
  <row>
    <udiDi>09345390000751</udiDi>
    <basicUdiDi>934539000TFCN-0102UU</basicUdiDi>
    <tradeName>MEDRAD® Salient Contrast Injection System</tradeName>
    <deviceName></deviceName>
    <manufacturerName>IMAXEON PTY LTD</manufacturerName>
    <manufacturerSrn>AU-MF-000009702</manufacturerSrn>
    <authorisedRepresentativeName>Bayer Medical Care B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000240</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Z11039013</emdnCode>
    <emdnDescription>ANGIOGRAPHIC INJECTORS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>DC009DW</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T14:34:33.952Z</lastUpdated>
  </row>
  <row>
    <udiDi>09345390001123</udiDi>
    <basicUdiDi>934539000TFCN-0099VY</basicUdiDi>
    <tradeName>MEDRAD® Centargo CT Injector System</tradeName>
    <deviceName></deviceName>
    <manufacturerName>IMAXEON PTY LTD</manufacturerName>
    <manufacturerSrn>AU-MF-000009702</manufacturerSrn>
    <authorisedRepresentativeName>Bayer Medical Care B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000240</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Z11039013</emdnCode>
    <emdnDescription>ANGIOGRAPHIC INJECTORS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CENT-SYS-BAT</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T14:34:33.934Z</lastUpdated>
  </row>
  <row>
    <udiDi>09345390001185</udiDi>
    <basicUdiDi>934539000TFCN-0099VY</basicUdiDi>
    <tradeName>MEDRAD® Centargo CT Injector System</tradeName>
    <deviceName></deviceName>
    <manufacturerName>IMAXEON PTY LTD</manufacturerName>
    <manufacturerSrn>AU-MF-000009702</manufacturerSrn>
    <authorisedRepresentativeName>Bayer Medical Care B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000240</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Z11039013</emdnCode>
    <emdnDescription>ANGIOGRAPHIC INJECTORS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CENT-SYS-BAT</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T14:34:33.917Z</lastUpdated>
  </row>
  <row>
    <udiDi>09345390001192</udiDi>
    <basicUdiDi>934539000TFCN-0099VY</basicUdiDi>
    <tradeName>MEDRAD® Centargo CT Injector System</tradeName>
    <deviceName></deviceName>
    <manufacturerName>IMAXEON PTY LTD</manufacturerName>
    <manufacturerSrn>AU-MF-000009702</manufacturerSrn>
    <authorisedRepresentativeName>Bayer Medical Care B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000240</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Z11039013</emdnCode>
    <emdnDescription>ANGIOGRAPHIC INJECTORS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CENT-SYS-OCS</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T14:34:33.904Z</lastUpdated>
  </row>
  <row>
    <udiDi>09345390001345</udiDi>
    <basicUdiDi>934539000TFCN-0102UU</basicUdiDi>
    <tradeName>MEDRAD® Salient Contrast Injection System</tradeName>
    <deviceName></deviceName>
    <manufacturerName>IMAXEON PTY LTD</manufacturerName>
    <manufacturerSrn>AU-MF-000009702</manufacturerSrn>
    <authorisedRepresentativeName>Bayer Medical Care B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000240</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Z11039013</emdnCode>
    <emdnDescription>ANGIOGRAPHIC INJECTORS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>DC009S</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T14:34:33.804Z</lastUpdated>
  </row>
  <row>
    <udiDi>09345390001352</udiDi>
    <basicUdiDi>934539000TFCN-0102UU</basicUdiDi>
    <tradeName>MEDRAD® Salient Contrast Injection System</tradeName>
    <deviceName></deviceName>
    <manufacturerName>IMAXEON PTY LTD</manufacturerName>
    <manufacturerSrn>AU-MF-000009702</manufacturerSrn>
    <authorisedRepresentativeName>Bayer Medical Care B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000240</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Z11039013</emdnCode>
    <emdnDescription>ANGIOGRAPHIC INJECTORS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>DC009SW</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T14:34:33.791Z</lastUpdated>
  </row>
  <row>
    <udiDi>09345390001376</udiDi>
    <basicUdiDi>934539000TFCN-0102UU</basicUdiDi>
    <tradeName>MEDRAD® Salient Contrast Injection System</tradeName>
    <deviceName></deviceName>
    <manufacturerName>IMAXEON PTY LTD</manufacturerName>
    <manufacturerSrn>AU-MF-000009702</manufacturerSrn>
    <authorisedRepresentativeName>Bayer Medical Care B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000240</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Z11039013</emdnCode>
    <emdnDescription>ANGIOGRAPHIC INJECTORS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>DC009DW</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T14:34:33.779Z</lastUpdated>
  </row>
  <row>
    <udiDi>09345390001475</udiDi>
    <basicUdiDi>934539000TFCN-0099VY</basicUdiDi>
    <tradeName>MEDRAD® Centargo CT Injector System</tradeName>
    <deviceName></deviceName>
    <manufacturerName>IMAXEON PTY LTD</manufacturerName>
    <manufacturerSrn>AU-MF-000009702</manufacturerSrn>
    <authorisedRepresentativeName>Bayer Medical Care B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000240</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Z11039013</emdnCode>
    <emdnDescription>ANGIOGRAPHIC INJECTORS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CENT-SYS-BAT</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T14:34:33.759Z</lastUpdated>
  </row>
</eudamedExport>